MedTrace Logo

BEAST: A Pilot Trial

NCT05416203 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2025-07-01

Study results available
· View outcomes & findings →

Summary

This pilot study trial will test the acceptability, feasibility, and usability of a brief enhanced anxiety sensitivity treatment to reduce anxiety sensitivity and functional impairment in Veterans.

Conditions

  • Anxiety Sensitivity
  • Functional Impairment

Interventions

BEHAVIORAL

Brief Enhanced Anxiety Sensitivity Treatment

BEAST is a CBT-based intervention that includes psychoeducation, identifying and challenging maladaptive thoughts, and interoceptive exposure. The intervention is delivered through a single virtual face-to-face session supplemented with a mobile app for two weeks after the face to face session.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Nicholas P Allan, PhD · VA Finger Lakes Healthcare System, Canandaigua, NY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2024-05-31
Completion
2024-08-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05416203 on ClinicalTrials.gov